Mylan's 400% price increase vs. Moral Obligation

Hello Monkeys. I’ve been following this story for quite some time now and I’m trying to make sense of both sides of the issue. It is understandable that these giant pharmaceutical companies, who create life saving drugs want to make profits. As do insurers, wholesalers, and distributers who all want there cut. They would’t be in business if they didn’t.

We are apart of this system where corporations have substantial power over determining how much the consumers pay. In some cases, where there is competition in a particular market, consumers can vote with their wallets. But with Mylan’s EpiPen, they have been forced to accept the $608 list price with lack of an alternative.

What makes the situation puzzling is when the CEO of Mylan admits publicly that:

No one’s more frustrated than me about EpiPen price

But how could she admit to being frustrated, when the facts say that her company has had the power to control these price increases? Instead she blames capitalism for the public outcry.

My question is... Should we leave it in the hands of big pharmaceutical companies to determine pricing?

When they have been known to create monopolies on particular life saving drugs, substantially raise the price, all while knowing that insurance companies won’t cover the outrageous cost.

Why does our system protect these companies instead of the families, who don’t have alternatives, and are forced paying these prices to avoid losing loved ones?

0 Comments

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • JPMorgan 01 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”